RxDoctor Payments Data

Sherissa-Nicole Sebastian, APRN

Psychiatric/Mental Health · Westminster, CONPI 1487313698

Payments from drug & device makers

$1,816in general payments, 2019–2025

Across 91 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$341
  • AbbVie$260
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$233
  • Neurocrine Biosciences, Inc.$174
  • Johnson & Johnson$134
  • Takeda Pharmaceuticals U.S.A., Inc.$129
  • plus $545 from 12 others

What the payments were for

  • Food & beverage$1,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,816 in reported general payments places this provider in the 85th percentile of 873 psychiatric/mental health providers in Colorado.

See all psychiatric/mental health providers in Colorado

Medicare billing

Part B allowed, 2024
$33,009
Medicare patients
41
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bupropion XlBupropion Hcl18$469
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$330
Quetiapine Fumarate22$242
Mirtazapine19$226
Duloxetine Hcl22$155
Trazodone Hcl14$97
Buspirone Hcl15$71
Sertraline Hcl13$42
Fluoxetine Hcl12$41

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →